Search results
Results From The WOW.Com Content Network
A look at the shareholders of OPKO Health, Inc. ( NASDAQ:OPK ) can tell us which group is most powerful. ... (NASDAQ:OPK) insiders have had a fantastic week as stock increased 5.1%, and they haven ...
OPKO Health is a diversified healthcare company present in more than 30 countries. The company's primary businesses include [citation needed] Bioreference Laboratories, a clinical laboratory with a core genetic testing business. The 4K Test Score, a blood test for prostate cancer. Pharmaceutical development, with products such as Rayaldee.
OPKO Health (OPK) closed the most recent trading day at $3.22, moving -0.92% from the previous trading session.
For premium support please call: 800-290-4726 more ways to reach us
Nasdaq Composite. The Nasdaq Composite ( ticker symbol ^IXIC) [1] is a stock market index that includes almost all stocks listed on the Nasdaq stock exchange. Along with the Dow Jones Industrial Average and S&P 500, it is one of the three most-followed stock market indices in the United States. The composition of the NASDAQ Composite is heavily ...
The company continued with its misleading statements and was able to raise $35 million by December 2003 from the sales of common stock. Information was leaked about the incomplete and misleading documents between late October and end of December 2003, which led to the stock dropping by 66% from the August 1, 2003 stock price.
Disappointing Q1 results weighed on the healthcare stock. For premium support please call: 800-290-4726 more ways to reach us
Michael Jaharis and Frost bought Key Pharmaceuticals, Inc. in 1972. [5] Frost was chairman of the board of directors of Key Pharmaceuticals, from 1972, until its acquisition by Schering-Plough in 1986, for $835 million. [6] Frost's share was $100 million. [7] Frost's estimated net worth in 1986 was $150 million.